Glycoprotein platelet inhibitors
What are Glycoprotein platelet inhibitors?
Glycoprotein platelet inhibitors prevent platelet adhesion by binding to the glycoprotein IIb/IIIa receptors on the plasma membrane of platelets. They stop the actual substrates of the glycoprotein receptors from binding to the receptor, so inhibit platelets from sticking together to form a thrombus, which can lead to stroke, myocardial infarction or deep vein thrombosis.
Glycoprotein platelet inhibitors are used in patients with angina, after a heart attack, angioplasty or other types of coronary vasculature procedures.
List of Glycoprotein platelet inhibitors
View by Generic | Brand
| Drug Name | Avg. Rating | Reviews |
|---|---|---|
| eptifibatide systemic (Pro) Brand name: Integrilin |
1 review | |
| tirofiban systemic (Pro) Brand name: Aggrastat | No reviews | |
| abciximab systemic Brand name: ReoPro | No reviews | |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
See also
Medical conditions treated or associated with glycoprotein platelet inhibitors:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.